Analystreport

Summit Therapeutics Inc. (NASDAQ: SMMT) was given a new $44.00 price target on by analysts at Jefferies Financial Group Inc..

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre